Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis

PHASE3CompletedINTERVENTIONAL
Enrollment

353

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
Hyperhidrosis
Interventions
DRUG

glycopyrronium Topical Wipes

Topical wipes containing glycopyrronium

OTHER

Vehicle

Vehicle (placebo) topical wipes

Trial Locations (20)

10022

Schweiger Dermatology Group, New York

14623

Skin Search of Rochester, Inc., Rochester

20850

Lawrence J Green, MD LLC, Rockville

37203

Clinical Research Associates, Inc., Nashville

46032

Shideler Clinical Research Center, Carmel

55424

Zel Skin & Laser Specialist, Edina

64506

MediSearch Clinical Trials, Saint Joseph

72758

Northwest Arkansas Clinical Trials Center, PLLC, Rogers

75231

Modern Research Associates, Dallas

77030

The University of Texas Dermatology Clinical Research Center, Houston

80210

Colorado Medical Research Center, Inc., Denver

84088

Jordan Valley Dermatology Center, West Jordan

84117

Dermatology Research Center, Inc., Salt Lake City

87106

Academic Dermatology Associates, Albuquerque

89044

Clinical Studies Group, LLC, Henderson

90045

Dermatology Research Associates, Los Angeles

90404

Clinical Science Institute, Santa Monica

97210

Oregon Dermatology and Research Center, Portland

98101

Dermatology Associates, Seattle

99202

Premier Clinical Research, Spokane

Sponsors
All Listed Sponsors
lead

Journey Medical Corporation

INDUSTRY

NCT02530294 - Study of Glycopyrronium in Subjects With Axillary Hyperhidrosis | Biotech Hunter | Biotech Hunter